31 results
8-K
EX-99.1
ITCI
Intra-Cellular Therapies, Inc.
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
support programs are highly effective at addressing coverage and reimbursement processes and overall patient affordability where appropriate.
CLINICAL
424B5
ITCI
Intra-Cellular Therapies, Inc.
5 Jan 22
Prospectus supplement for primary offering
4:51pm
Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, or collectively, ACA, became law in the United States
424B5
ITCI
Intra-Cellular Therapies, Inc.
3 Jan 22
Prospectus supplement for primary offering
5:30pm
by the Health Care and Education Affordability Reconciliation Act of 2010, or collectively, ACA, became law in the United States. The ACA substantially changed
424B5
sr8gw1xgq769qr6sy
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
xyb6w49
9 Sep 20
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
ylw8jnas
10 Aug 20
Intra-cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:52am
8-K
EX-99.1
kfnsw 4bg6q0p14zr
7 May 20
Intra-cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update
7:42am
8-K
EX-99.1
3fqrruvq3c9mwhjfo
23 Mar 20
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
7:52am
424B5
595xb0 kb5pj
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
pgmn 2kbdjbt
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
v1ze3q byaszzb
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
iffbq7aui6m6x
6 Jan 20
Automatic shelf registration
4:02pm